Merck KGaA MKKGY
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 6.32B | 6.01B | 6.11B | 6.22B | 5.96B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.32B | 6.01B | 6.11B | 6.22B | 5.96B |
| Cost of Revenue | 2.64B | 2.42B | 2.57B | 2.46B | 2.53B |
| Gross Profit | 3.68B | 3.59B | 3.54B | 3.76B | 3.44B |
| SG&A Expenses | 1.82B | 1.78B | 1.79B | 1.71B | 1.68B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 190.74M | -53.12M | -58.20M | -149.65M | 137.33M |
| Total Operating Expenses | 5.44B | 4.91B | 5.03B | 4.79B | 4.95B |
| Operating Income | 875.80M | 1.09B | 1.08B | 1.43B | 1.01B |
| Income Before Tax | 744.37M | 1.02B | 466.80M | 1.31B | 940.86M |
| Income Tax Expenses | 169.81M | 234.00M | 89.64M | 263.05M | 197.48M |
| Earnings from Continuing Operations | 574.56M | 782.39M | 377.17M | 1.05B | 743.38M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -4.65M | -10.88M | -5.82M | 4.68M | -3.40M |
| Net Income | 569.91M | 771.50M | 371.35M | 1.05B | 739.97M |
| EBIT | 875.80M | 1.09B | 1.08B | 1.43B | 1.01B |
| EBITDA | 1.45B | 1.66B | 1.52B | 1.96B | 1.50B |
| EPS Basic | 1.31 | 1.78 | 0.85 | 2.42 | 1.70 |
| Normalized Basic EPS | 1.06 | 1.44 | 1.83 | 1.89 | 1.35 |
| EPS Diluted | 1.31 | 1.78 | 0.85 | 2.42 | 1.70 |
| Normalized Diluted EPS | 1.06 | 1.44 | 1.83 | 1.89 | 1.35 |
| Average Basic Shares Outstanding | 433.63M | 433.82M | 434.80M | 435.75M | 434.67M |
| Average Diluted Shares Outstanding | 433.63M | 433.82M | 434.80M | 435.75M | 434.67M |
| Dividend Per Share | -- | -- | 2.56 | -- | -- |
| Payout Ratio | 208.98% | 2.06% | 0.00% | -- | 152.30% |